SIG
49
2
DLTR
31
-3
KMX
58
-2
AA
63
7
SBUX
39
7
DOW
35
-5
GRMN
73
2
TDC
70
15
WMT
63
3
WU
22
2
NEM
42
10
VTR
50
3
IRM
46
5
RRC
58
5
R
75
3
GWW
78
2
FLS
78
3
WY
56
3
PVH
65
-3
WHR
70
2
SIG
49
2
DLTR
31
-3
KMX
58
-2
AA
63
7
SBUX
39
7
DOW
35
-5
GRMN
73
2
TDC
70
15
WMT
63
3
WU
22
2
NEM
42
10
VTR
50
3
IRM
46
5
RRC
58
5
R
75
3
GWW
78
2
FLS
78
3
WY
56
3
PVH
65
-3
WHR
70
2
Financhill
Back

LanzaTech Global 10K Form

Sell
42

LNZA
LanzaTech Global

Last Price:
1.70
Seasonality Move:
-2.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LNZA News And Ratings

See the #1 stock for the next 7 days that we like better than LNZA

LNZA Financial Statistics

Sales & Book Value

Annual Sales: $62.63M
Cash Flow: $-16.44M
Price / Cash Flow: 0
Annual Sales: $0.34
Price / Book: 4.98

Profitability

EPS (TTM): -0.49000
Net Income (TTM): $-97.31M
Gross Margin: $17.65M
Return on Equity: -79.25%
Return on Assets: -39.99%

LanzaTech Global Earnings Forecast

Key LanzaTech Global Financial Ratios

  • The Gross Profit Margin over the past 4 years for LNZA is 28.18%.
  • The Selling, General & Administrative Expenses for LNZA have been equal to 80.53% of Gross Profit Margin.
  • The Research & Development expenses have been 108.80% of Revenue.
  • The Interest Expense is -0.01% of Operating Income.
  • The Net Earning history of LNZA is -214.11% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

LanzaTech Global Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial Services & Supplies
Sector: Industrials
Current Symbol: LNZA
Website: lanzatech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.4
Quick Ratio: 3.89

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

LNZA Technical Analysis vs Fundamental Analysis

Sell
42
LanzaTech Global (LNZA) is a Sell

Is LanzaTech Global a Buy or a Sell?

  • LanzaTech Global stock is rated a Sell
    The current LanzaTech Global [LNZA] share price is $1.70. The Score for LNZA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.